Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform



Developer of a next-generation phenotypic screening platform called to identify the best new targets for future therapy, and crucially, how to drug them. The company's platform can systematically unmask hidden, or cvryptic druggable sites in the human genome and directly link them to useful therapeutic functions in a live-cell context. Its platform uses these functionally validated protein fragments to then rapidly inform the design of small molecule drugs with the same shape, providing a continuous pipeline of highly validated first-in-class drug discovery programmes for out-licensing to Pharma.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • Office 2055, Building 250
  • Babraham Research Campus, Cambridgeshire
  • Cambridge CB22 3AT
  • England, United Kingdom

+44 01223 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore PhoreMost’s full profile, request a free trial.

PhoreMost Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 21-Sep-2018 $14.3M 000.00 Completed Product Development
4. Grant 27-Apr-2018 00.000 Completed Product Development
3. Grant 15-Jun-2017 00.000 Completed Product Development
2. Grant 13-May-2015 $2.14M $6.12M Completed Startup
1. Seed Round 11-Mar-2015 $6.12M $6.12M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

PhoreMost Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aviva Systems Biology Corporation San Diego, CA 0
000000 000000 Venture Capital-Backed South San Francisco, CA 0 00.00 000000000000 00.00
0000000 Venture Capital-Backed San Diego, CA 00 000.00 0000000000 0 000.00
000000000 Formerly VC-backed Milpitas, CA 000 000000&0
0000000 Accelerator/Incubator Backed San Francisco, CA 0 000000000000
To view this company’s complete list of competitors, request access »

PhoreMost Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Morningside Group PE/Buyout Minority 000 0000 000000 0
Innovate UK Government Minority 000 0000 000000 0
Amadeus Capital Partners Venture Capital Minority 000 0000 000000 0
Cambridge Angels Angel Group Minority 000 0000 000000 0
Cambridge Enterprise Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

PhoreMost Executive Team (7)

Name Title Board
Christopher Torrance Ph.D Co-Founder, Board Member & Chief Executive Officer
Markus Muellner Ph.D Chief Technology Officer
Grahame McKenzie Ph.D Co-Founder & Chief Scientific Officer
Ashok Venkitaraman Ph.D Co-Founder & Company Director
Charli Batley Ph.D Director, Operations

1 Former Executive

You’re viewing 5 of 7 executives. Get the full list »

PhoreMost Board Members (4)

Name Representing Role Since Contact
Christopher Torrance Ph.D PhoreMost Co-Founder, Board Member & Chief Executive Officer 000 0000
Gerald Chan Ph.D Morningside Group Board Member 000 0000
Hermann Hauser Ph.D Amadeus Capital Partners Board Member 000 0000
Jonathan Milner Ph.D Self Chairman & Company Director 000 0000